» Articles » PMID: 19473558

Intraarticular Administration of Platelet-rich Plasma with Biodegradable Gelatin Hydrogel Microspheres Prevents Osteoarthritis Progression in the Rabbit Knee

Overview
Specialty Rheumatology
Date 2009 May 29
PMID 19473558
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the therapeutic potential of administration of gelatin hydrogel microspheres containing platelet-rich plasma (PRP), by examining its effects on progression of osteoarthritis (OA) in a rabbit model.

Methods: PRP and platelet-poor plasma (PPP) were prepared from rabbit blood. Adult rabbit chondrocytes were cultured in the alginate beads with the presence of 3% PRP or 3% PPP. Glycosaminoglycan (GAG) synthesis was quantified using dimethylmethylene blue assay. To confirm the anabolic effect of PRP in vivo, cartilage matrix gene expression was examined after intraarticular administration of PRP contained in gelatin hydrogel microspheres. The PRP contained in gelatin hydrogel microspheres was administered into the rabbit knee joint twice with an interval of 3 weeks, beginning 4 weeks after anterior cruciate ligament transection (ACLT). Ten weeks after ACLT, gross morphological and histological examinations were performed.

Results: PRP significantly stimulated chondrocyte GAG synthesis in vitro. In the knee joint, expression of proteoglycan core protein mRNA in the articular cartilage increased after administration of PRP contained in microspheres. Intraarticular injections of PRP in gelatin hydrogel microspheres significantly suppressed progression of OA in the ACLT rabbit model morphologically and histologically.

Conclusion: The present findings indicate that sustained release of growth factors contained in PRP has preventive effects against OA progression. These preventive effects appear to be due to stimulation of cartilage matrix metabolism, caused by the growth factors contained in PRP.

Citing Articles

Therapeutic Controlled Release Strategies for Human Osteoarthritis.

Wang D, Liu W, Venkatesan J, Madry H, Cucchiarini M Adv Healthc Mater. 2024; 14(2):e2402737.

PMID: 39506433 PMC: 11730424. DOI: 10.1002/adhm.202402737.


The use of platelet rich plasma in the treatment of degenerative joint disease in cats: an exploratory case series.

Huntingford J, Looney A, Johnson J, Miller L Front Vet Sci. 2024; 11:1394055.

PMID: 38863451 PMC: 11165359. DOI: 10.3389/fvets.2024.1394055.


Global research trends and hotspots in patellofemoral pain syndrome from 2000 to 2023: a bibliometric and visualization study.

Xu J, Cai Z, Chen M, Wang X, Luo X, Wang Y Front Med (Lausanne). 2024; 11:1370258.

PMID: 38566926 PMC: 10985266. DOI: 10.3389/fmed.2024.1370258.


Mesenchymal Stem Cells Cultured in a 3D Microgel Environment Containing Platelet-Rich Plasma Significantly Modify Their Chondrogenesis-Related miRNA Expression.

Mata M, Salvador-Clavell R, Rodenas-Rochina J, Sancho-Tello M, Gallego Ferrer G, Ribelles J Int J Mol Sci. 2024; 25(2).

PMID: 38256011 PMC: 10815493. DOI: 10.3390/ijms25020937.


Management of chondral and osteochondral lesions of the hip : A comprehensive review.

Itha R, Vaishya R, Vaish A, Migliorini F Orthopadie (Heidelb). 2023; 53(1):23-38.

PMID: 37815635 PMC: 10781822. DOI: 10.1007/s00132-023-04444-9.